BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 19, 2020
View Archived Issues
Circulating miR-638 and miR-521: potential screening biomarkers for cervical squamous cell carcinoma
Read More
Acid test for therapeutic peptides
Read More
Mersana begins phase I study of XMT-1592 in NSCLC and ovarian cancer
Read More
Interim phase I data presented for mRNA-1273 coronavirus vaccine
Read More
Cellect's ApoGraft to be studied for treatment of COVID-19-related pulmonary diseases
Read More
Namodenoson reduces liver fat and fibrosis in phase II NAFLD study
Read More
FDA clears IND application for phase II study of merimepodib in advanced COVID-19
Read More
LATS2 and KIBRA are prognostic markers in patients with ccRCC
Read More
Intermediary results presented for VLP COVID-19 vaccine in mice
Read More
Heron Therapeutics initiates phase Ib/II study of HTX-034 for postoperative pain
Read More
Human L-opsin gene therapy shows potential for treating blue cone monochromacy
Read More
Incyte presents novel PI3K-gamma inhibitors
Read More
Janssen discovers novel potent EP inhibitors
Read More
ELX-01 shows functional activity in a model of nonsense mutation-related IRD
Read More
Metacrine patents new AOC3 inhibitors
Read More
Arrien Pharmaceuticals synthesizes MELK and/or FLT3 inhibitors
Read More
Bristol-Myers Squibb presents new Toll-like receptor antagonists
Read More
New adjuvant reverses MDR in Gram-negatives
Read More
New ATR kinase inhibitors identified by Repare Therapeutics
Read More
Maxinovel Pharmaceuticals patents PD-1/PD-L1 interaction inhibitors
Read More
FDA approves Tecentriq for first-line metastatic NSCLC with high PD-L1 expression
Read More
Sorrento's STI-1499 demonstrates 100% inhibition of SARS-CoV-2 virus infection in vivo
Read More
European Commission grants conditional approval for Zolgensma for SMA
Read More
Phase IIb study of Liproca Depot in prostate cancer meets endpoints
Read More